Pharma News

Treating high blood pressure with antihypertensive medication can greatly reduce your risk for heart attack, stroke and heart failure, but such treatment cannot undo all of the previous damage or restore cardiovascular disease risk to ideal levels, says a study.

Scientists at the Georgia Institute of Technology, Atlanta suggest that humans may be able to regrow their own teeth in the same way as a cichlid fish in Malawi lake. The study was published in the journal Proceedings of the National Academy of Sciences.

Novartis acquire Admune, a clinical-stage biotech company focused on the development and delivery of cytokine therapy drugs for cancer, for the company’s IL-15 agonist program, currently in Phase I clinical trials for metastatic cancer. The fee is not being disclosed. Novartis also signed a $15 million licensing agreement with Palobiofarma. The company, based at Barcelona’s science park, focuses on the discovery and development of new drugs based on the modulation of adenosine receptors.

DelMar Pharmaceuticals, a biopharmaceutical company focused on the development and commercialization of new cancer therapies, announced that it presented positive preclinical data demonstrating the promising potential of its lead product candidate VAL-083 (dianhydrogalactitol) as a treatment for ovarian cancer.

The country has witnessed an increase in availability of allopathic doctors with their number standing at 9.38 lakhs, according to National Health Profile-2015, which was released by Union Health Minister J P Nadda. The National Health Profile-2015, published by the Central Bureau of Health Intelligence (CBHI), said that up to 2014, the country has 9,38,861 doctors possessing recognised medical qualifications under the Indian Medical Council Act.

India has one of the highest rates of antibiotic resistance in the world, said a recent report, stressing on limiting the use of antibiotics through improved water, sanitation and immunisation.

[adsense:336x280:8701650588]

With a large number of tribal population suffering from sickle-cell anaemia and thalassemia, the government has established a research centre in Chandrapur in Maharashtra to help early detection and control of these blood related disorders. The Union Health Ministry said that the Indian Council of Medical Research (ICMR) has initiated efforts to set up a satellite centre of National Institute of Haemoglobinopathies (Mumbai) in the Chandrapur district. The Ministry said that since the establishment of a permanent centre may take time, ICMR has acquired a portion of the district TB Hospital in Chandrapur to start the research activities.

Edwards Lifesciences Corporation, a global leader in the science of heart valves and hemodynamic monitoring, has received US Food and Drug Administration (FDA) approval for aortic valve-in-valve procedures using the Edwards Sapien XT transcatheter heart valve.

A preliminary research presented at a US medical conference suggests that cancer drug may be helpful in improving memory and motor skills in patients with Parkinson's disease. The trial at Georgetown University involved 12 people who had Parkinson's or a related condition called Lewy body dementia.

Johnson & Johnson's Stelara was significantly better than placebo at inducing clinical response and remissions in patients with moderate to severe Crohn's disease. Crohn's disease is a chronic inflammatory condition of the gastrointestinal tract that affects about 700,000 Americans and 250,000 Europeans. Symptoms can include frequent diarrhea, abdominal pain and rectal bleeding. Stelara, a biotech medicine that blocks inflammation, is approved to treat the skin condition scaly plaque psoriasis and a type of arthritis associated with psoriasis.